Skip to content

Coagulation in Lamin A-C mutations

Coagulation in Lamin A-C mutations - Role of coagulation in patients with lamin A-C mutations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33410
Enrollment
90
Registered
2009-09-16
Start date
2009-06-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enhanced coagulation hypercoagulation

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Cases: Known LMNA mutation; adult men and women Controls: non-carrier family members

Exclusion criteria

Exclusion criteria: cases: LMNA mutations not known controls: LMNA mutations not examinated

Design outcomes

Primary

MeasureTime frame
Determination of the coagulable state.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)